World Journal of Surgical Oncology · 2006 · 50 citations · 14 references
MedicineEndocrinologyOncologyEndocrine OncologyMetastasisNeoplasiaEndocrine Tumor PrognosisParathyroid CancerParathyroid DisordersParathyroid NeoplasmsThyroid CancerThyroid DisordersCalcitonin-secreting TumorsMedullary Thyroid Carcinoma DiagnosisMedullary Thyroid Carcinoma PathologyMetastatic Tumors To The ThyroidThyroid Cancer Pathology
BACKGROUND: Medullary thyroid carcinomas (MTC) constitute about 5 to 7% of thyroid neoplasms. They originate from parafollicular C cells which produce Calcitonin, a hormone which has an impact on calcium metabolism and represents the biochemical activity of MTC. In rare cases pre-operative serum calcitonin can be negative. CASE PRESENTATION: We report on a 73-year-old female patient with a rare case of a serum calcitonin negative medullary thyroid carcinoma who suffered fulminant post-operative course and died of multiple metastasis. CONCLUSION: This case shows that in very rare cases MTCs do not secrete calcitonin making diagnosis and tumour follow-up difficult. To this date, only few reports describing this combination of circumstances were found in the English literature.
14
Rossella Elisei, Valeria Bottici, Fabiana Luchetti et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 537 citations · Full text
Medicine, Endocrinology, Radiology +17
Immunoassay of Human Calcitonin
Armen H. Tashjian, Barbara G. Howland, Kenneth E. W. Melvin et al. · New England Journal of Medicine · 1970 · 310 citations
Medicine, Endocrinology, Oncology +15
Furio Pacini, Marco Fontanelli, Laura Fugazzola et al. · The Journal of Clinical Endocrinology & Metabolism · 1994 · 252 citations